Rating History for SAB Biotherapeutics (SABS) by Argus

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/7/2026 N/A New Coverage Buy
(N/A)
7.00
(N/A)
3.62
(3.79)
4.7% Details